Form D — Inversion Therapeutics, Inc.
0001231919-25-000167 · filed 2025-08-27
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $11,110,779
- Total sold
- $6,910,684
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Inversion Therapeutics, Inc.
- CIK
- 2077706
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 1341 COLUMBUS AVENUE
BURLINGAME, CA 94010 - Phone
- 650-430-5176
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James A. Wells, Ph.D. · Executive OfficerBurlingame, CA Find on LinkedIn ↗
-
Jeremy Caldwell, Ph.D. · DirectorBurlingame, CA Find on LinkedIn ↗
-
William Michael Kavanaugh, M.D. · DirectorBurlingame, CA Find on LinkedIn ↗
-
Samad Wahid, M.D. · DirectorBurlingame, CA Find on LinkedIn ↗
View original on SEC EDGAR.